Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
P/B ratio for Zentek Ltd. (ZTEK)
P/B ratio as of 2023: 7.69
According to Zentek Ltd.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.69. At the end of 2022 the company had a P/B ratio of 6.77.
P/B ratio history for Zentek Ltd. from 2009 to 2023
P/B ratio at the end of each year
| Year | P/B ratio |
|---|---|
| 2023 | 7.69 |
| 2022 | 6.77 |
| 2021 | 10.29 |
| 2020 | 8.05 |
| 2019 | 0.90 |
| 2018 | 1.08 |
| 2017 | 1.80 |
| 2016 | 2.74 |
| 2015 | 2.39 |
| 2014 | 5.12 |
| 2013 | 8.38 |
| 2012 | 4.72 |
| 2011 | 1.51 |
| 2010 | 1.33 |
| 2009 | 0.48 |